FR2391189A1 - Derives de la 2-aminotetraline, leur preparation et leurs utilisations therapeutiques - Google Patents

Derives de la 2-aminotetraline, leur preparation et leurs utilisations therapeutiques

Info

Publication number
FR2391189A1
FR2391189A1 FR7814616A FR7814616A FR2391189A1 FR 2391189 A1 FR2391189 A1 FR 2391189A1 FR 7814616 A FR7814616 A FR 7814616A FR 7814616 A FR7814616 A FR 7814616A FR 2391189 A1 FR2391189 A1 FR 2391189A1
Authority
FR
France
Prior art keywords
preparation
therapeutic uses
aminotetraline derivatives
derivatives
aminotetraline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7814616A
Other languages
English (en)
Other versions
FR2391189B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of FR2391189A1 publication Critical patent/FR2391189A1/fr
Application granted granted Critical
Publication of FR2391189B1 publication Critical patent/FR2391189B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Dérivés de la 2-aminotétraline, leur préparation et leurs utilisations thérapeutiques. Ces composés répondent à la formule générale :
FR7814616A 1977-05-17 1978-05-17 Derives de la 2-aminotetraline, leur preparation et leurs utilisations therapeutiques Granted FR2391189A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52056837A JPS6045180B2 (ja) 1977-05-17 1977-05-17 ２−アミノテトラリン誘導体

Publications (2)

Publication Number Publication Date
FR2391189A1 true FR2391189A1 (fr) 1978-12-15
FR2391189B1 FR2391189B1 (fr) 1981-07-17

Family

ID=13038499

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814616A Granted FR2391189A1 (fr) 1977-05-17 1978-05-17 Derives de la 2-aminotetraline, leur preparation et leurs utilisations therapeutiques

Country Status (9)

Country Link
US (1) US4239903A (fr)
JP (1) JPS6045180B2 (fr)
CH (1) CH642941A5 (fr)
DE (1) DE2821584A1 (fr)
FR (1) FR2391189A1 (fr)
GB (1) GB1594687A (fr)
IT (1) IT1115077B (fr)
MX (1) MX5315E (fr)
NL (1) NL7805309A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0270947A2 (fr) * 1986-12-10 1988-06-15 Bayer Ag 2-Aminotétralines basiques substitués
WO1990015047A1 (fr) * 1989-05-31 1990-12-13 The Upjohn Company Derives de 2-aminotetraline therapeutiquement utiles
EP0420064A2 (fr) * 1989-09-25 1991-04-03 Northwestern University 2-Amido-tétralines substituées, comme agonistes et antagonistes de la mélatonine
US5153225A (en) * 1986-12-10 1992-10-06 Bayer Aktiengesellschaft Substituted basic 2-aminotetralin in pharmaceuticals

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545755A (en) * 1989-05-31 1996-08-13 The Upjohn Company Therapeutically useful 2-aminotetralin derivatives
WO2023129909A1 (fr) * 2021-12-27 2023-07-06 ATAI Life Sciences AG Activateurs d'aminotéraline de recepteurs de serotonine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2112899A (en) * 1935-03-09 1938-04-05 Squibb & Sons Inc Derivatives of ac-tetrahydro-betanaphthylamine
DE1126889B (de) * 1957-11-23 1962-04-05 Philips Nv Verfahren zur Herstellung neuer, in ihrer Wirkung modifizierter, eine Vereinfachung des Reserpinmolekuels darstellender, substituierter Amine mit blutdrucksenkender und spasmolytischer Wirkung
DE1225662B (de) * 1962-05-11 1966-09-29 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von basischen 3,5-Dimethoxy-4-alkoxy-benzoesaeureestern und deren Saeureadditionssalzen
FR2051486B1 (fr) * 1969-05-29 1973-06-08 Orsymonde

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0270947A2 (fr) * 1986-12-10 1988-06-15 Bayer Ag 2-Aminotétralines basiques substitués
EP0270947A3 (en) * 1986-12-10 1988-12-28 Bayer Ag Substituted basic 2-aminotetralines
US4880802A (en) * 1986-12-10 1989-11-14 Bayer Aktiengesellschaft Substituted basic 2-aminotetralin useful as cardiotonic agents
US5026857A (en) * 1986-12-10 1991-06-25 Bayer Aktiengesellschaft Substituted basic 2-aminotetralin in pharmaceuticals
US5153225A (en) * 1986-12-10 1992-10-06 Bayer Aktiengesellschaft Substituted basic 2-aminotetralin in pharmaceuticals
WO1990015047A1 (fr) * 1989-05-31 1990-12-13 The Upjohn Company Derives de 2-aminotetraline therapeutiquement utiles
EP0420064A2 (fr) * 1989-09-25 1991-04-03 Northwestern University 2-Amido-tétralines substituées, comme agonistes et antagonistes de la mélatonine
EP0420064A3 (en) * 1989-09-25 1992-02-26 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists

Also Published As

Publication number Publication date
IT1115077B (it) 1986-02-03
JPS53141254A (en) 1978-12-08
MX5315E (es) 1983-06-17
DE2821584C2 (fr) 1992-01-02
CH642941A5 (de) 1984-05-15
GB1594687A (en) 1981-08-05
DE2821584A1 (de) 1978-11-30
IT7849382A0 (it) 1978-05-16
US4239903A (en) 1980-12-16
JPS6045180B2 (ja) 1985-10-08
NL7805309A (nl) 1978-11-21
FR2391189B1 (fr) 1981-07-17

Similar Documents

Publication Publication Date Title
FR2359115A1 (fr) Derives tetraalkyles de bis-cyclohexylamines et leur preparation
FR2375249A1 (fr) Nouveaux derives de la muramyldipeptide utiles notamment comme immuno-adjuvants et leur procede de preparation
FR2370731A1 (fr) Nouveaux derives de la piperidine polysubstitues, leurs procedes de preparation et leur application pharmaceutique
FR2354338A1 (fr) Acides n-phosphonomethylene-monoaminoalcane-mono- et polyphosphoniques et acides n-phosphonomethylene-diaminoalcane-polyphosphoniques, et leur preparation
FR2370733A1 (fr) Derives polysubstitues de la piperidine, leurs procedes de preparation et leur application en tant que medicaments
FR2430418A1 (fr) Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques
FR2384811A1 (fr) Derives de la neocarzinostatine, leur application therapeutique et leur procede de preparation
FR2405941A1 (fr) Nouveaux derives sesquiterpeniques utiles notamment comme inhibiteurs du systeme complementaire et leurs procedes de preparation
FR2429797A1 (fr)
FR2397385A1 (fr) Derives du resorcinol, leur preparation et leurs utilisations therapeutiques
FR2427335A1 (fr) Derives du 5-nitro-imidazole, leur preparation et leurs utilisations comme medicaments antiprotozoaires
FR2422658A1 (fr) Composes piperazinyl-benzoheterocycliques, leur preparation et leurs utilisations therapeutiques
FR2377396A1 (fr) Dithienylalkylamines, leur preparation et leurs utilisations therapeutiques
FR2415097A1 (fr) Derives de l'anthraquinone, leur procede de preparation et leur utilisation
FR2367742A1 (fr) Derives d'a-thio-alcanoiques, leur preparation et leur utilisation
FR2391189A1 (fr) Derives de la 2-aminotetraline, leur preparation et leurs utilisations therapeutiques
FR2387269A1 (fr) Melanges de colorants azoiques, leur preparation et leurs utilisations
FR2442226A1 (fr) Anilines substituees, leur preparation et leurs utilisations
FR2377386A1 (fr) Nouveaux derives de la pyrazoline, leur procede de preparation et leur application comme azureurs
FR2383163A1 (fr) Derives aromatiques et azotes de l'acetamide, leur preparation et leur utilisation therapeutique comme anti-arythmiques
FR2397405A1 (fr) Derives de la 2-pyridone utilisables comme regulateurs de la croissance des vegetaux
FR2387215A1 (fr) 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives
FR2372164A1 (fr) Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques
FR2433516A1 (fr) Pyridoxines, leur preparation et leurs utilisations therapeutiques
FR2401922A1 (fr) Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques

Legal Events

Date Code Title Description
ST Notification of lapse